share_log

Reviva Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Parag Saxena(19.9%),Vedanta Partners, LLC(19.4%), etc.

Reviva Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Parag Saxena(19.9%),Vedanta Partners, LLC(19.4%)等

美股sec公告 ·  2023/11/30 16:49
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息